• Join
  • Login
  • Contact

Global Pharmaceutical Observatory

The Global Pharmaceutical Observatory (GPO), developed and maintained by FIP, is a worldwide data hub informing the advocacy work of our members and partners including in areas of policy development, decision-making, the advancement of pharmaceutical practice, health and life-sciences, education and skills training, and, of course, workforce intelligence.  We have developed the vision and mission for the GPO in collaboration with our members.

Vision of FIP’s GPO (5 year)

The GPO will become the most comprehensive and most respected source of data and intelligence on pharmacy workforce, pharmacy practice and pharmaceutical science worldwide.  The observatory provides a window on the work and impact of the global pharmaceutical community wherever you are.

FIP’s GPO mission (Present state)

Our mission is to collate and validate, effectively and efficiently, global data on the pharmacy workforce, practice and pharmaceutical science. We undertake comprehensive analyses and provide accessible, high quality intelligence that supports our member organisations in their work. We communicate this innovatively, thereby promoting our member organisations’ contribution to health. We provide evidence-based strategic information, reports and guidance on the application of pharmaceutical science, policies, practices and services.

To do this, we engage with and work in partnership with our member organisations, key stakeholders and global thought-leaders.

By delivering this mission, we will contribute to the wider FIP Development Goals and the United Nations’ Sustainable Development Goals.

An update of the GPO was presented at this FIP Virtual 2020 event: "ONE FIP: re-imagining the possible with data (powered by GPO)":

Tracking the FIP Development Goals

Progress with the FIP Development Goals are measured and monitored via the data collected in the GPO.

One FIP GPO Data & Intelligence Commission

The commission provides strategic advice to FIP on the advocacy and delivery of the GPO project, focusing on achievement of the vision and the strategic objectives through member engagement. It is chaired by Robert Sindelar, professor and dean emeritus of the Faculty of Pharmaceutical Sciences, University of British Columbia, Canada. Members of the commission, who have been selected to ensure that the GPO has regional applicability and sectoral relevance and who together provide a breadth of experience globally, are as follows:

•    Nadia Al Mazrouei (Eastern Mediterranean Pharmaceutical Forum)
•    Naoko Arakawa (FIP Academic Pharmacy Section)
•    Denis Awitty (African Pharmaceutical Forum)
•    Al Carter (FIP Regulators Forum)
•    Paul Fahey (FIP Technology Forum)
•    Paul Gallagher (FIP Academic Institution Members)
•    Prosper Hiag (African Pharmaceutical Forum)
•    John Jackson (Western Pacific Pharmaceutical Forum)
•    Oussama Madadi (International Pharmaceutical Students’ Federation)
•    Rob Moss  (FIP Hospital Pharmacy Section)
•    Ayman Noreddin (Eastern Mediterranean Pharmaceutical Forum)
•    Leonila Ocampo (Western Pacific Pharmaceutical Forum)
•    Virginia Olmos (Pharmaceutical Forum of the Americas)
•    Sonia Queiros  (FIP member organisations in Europe)
•    Lorena Quirós (Pharmaceutical Forum of the Americas)
•    Adam Rathbone (FIP Young Pharmacists Group)
•    Charlotte Rossing (FIP Board of Pharmaceutical Sciences)
•    Rikke Løvig Simonsen (FIP member organisations in Europe)
•    Lars-Åke Söderlund (FIP Community Pharmacy Section)
•    Rao Vadlamudi (South East Asia Region Pharmaceutical Forum)

One FIP GPO Data & Intelligence Commission Terms of Reference

For more about FIP’s GPO, click here.




Last update 18 July 2022

FIP Congresses